Kinetics of Intestinal Presence of Spores Following Oral Administration of Bacillus clausii Formulations: Three Single-Centre, Crossover, Randomised, Open-Label Studies

Pierluigi Navarra,Stefano Milleri,Marcos Perez III,Maria Chiara Uboldi,Paolo Pellegrino,Beatrice Bois De Fer,Lorenzo Morelli
DOI: https://doi.org/10.1007/s13318-021-00676-2
2021-03-08
European Journal of Drug Metabolism and Pharmacokinetics
Abstract:Probiotics are live microorganisms that may provide benefits including the prevention of gastrointestinal disorders and other diseases. Enterogermina is a probiotic mix of spores from four strains of <i>Bacillus clausii</i> (O/C, T, N/R and SIN), available in several oral formulations. The objective of this analysis was to evaluate and compare the kinetic profiles of different formulations of Enterogermina—vial [E4 once daily (OD) and E2 twice daily (BID)], capsule [EC2 three times daily (TID)], oral powder for suspension (ES6 OD) and oral powder not requiring suspension (E6 OD) from two studies from 2012 (EUDRACT 2010-024497-19 and 2010-023187-41) and one study from 2016 (EUDRACT 2015-003330-27).
pharmacology & pharmacy
What problem does this paper attempt to address?